Is there a problem with inhaled long-acting β-adrenergic agonists?

Publisher Website

31 January 2006

journal article
review article
Published by Elsevier in Journal of Allergy and Clinical Immunology

Vol. 117 (1), 3-16
https://doi.org/10.1016/j.jaci.2005.10.013

Abstract

No abstract available

Keywords

SHORT-ACTING Β-AGONISTS; LONG-ACTING Β-AGONISTS; ADVERSE REACTIONS; ASTHMA MORTALITY; Β-ADRENERGIC RECEPTOR GENOTYPES
ACRN; ASTHMA CLINICAL RESEARCH NETWORK; BAL; BRONCHOALVEOLAR LAVAGE; LABA; LONG-ACTING Β2-ADRENERGIC BRONCHODILATOR; OR; ODDS RATIO; PEF; PEAK EXPIRATORY FLOW; RR; RELATIVE RISK; SMART; SALMETEROL MULTICENTER ASTHMA RESEARCH TRIAL

Cited by 55 articles